Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Observational 2Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 3

Conditions

Neoplasms 10Neoplasm Metastasis 3

Interventions

pembrolizumab 34Specimen Handling 26Magnetic Resonance Spectroscopy 26Radiosurgery 25Biopsy 25Gemcitabine 22Nivolumab 21Paclitaxel 18Carboplatin 16Bevacizumab 15Trastuzumab 14Everolimus 12Radiotherapy 11Irinotecan 11trastuzumab deruxtecan 10atezolizumab 10Erlotinib Hydrochloride 10Docetaxel 10Cetuximab 10Capecitabine 10Albumin-Bound Paclitaxel 10130-nm albumin-bound paclitaxel 10Sorafenib 9Ipilimumab 9Cisplatin 9Taxes 8Standard of Care 8Oxaliplatin 8Drug Therapy 8olaparib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Neoplasm Metastasis × Data Collection × Tumor-Agnostic × Clear all
NCT02312960 2025-03-25

Radium-223 Dichloride Long-term Follow-up Program

Bayer

Phase 4 Completed
255 enrolled 31 charts
Tumor-Agnostic

Neoplasm Metastasis

NCT03995927 2023-06-29

PROCC

Wake Forest University Health Sciences

Terminated
15 enrolled
Tumor-Agnostic

Neoplasm Metastasis

NCT04921553 2021-08-02

TRacKING

Centre Leon Berard

Unknown
500 enrolled
Tumor-Agnostic

Neoplasm Metastasis, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡